However, for T2DM patients with a long duration and those who have previously used hypoglycemic drugs, such as sulfonylureas and other insulin secretagogue, insulin levels cannot truly reflect the islet β-cell function, and a homeostasis model evaluation may not reflect the degree of insulin resistance in T2DM patients. The gene discussed is INS; the disease is Insulin resistance.